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Ozone-autohemotherapy (O3-AHT) has recently gained interest as a form of alternative and 
complementary medicine. There is, however, some concern regarding its toxicity and effectiveness. 
Ozone is a powerful oxidant and when introduced into biological fluids react with most cellular 
components including proteins, lipids and DNA. We assessed the effect of O3-AHT on peripheral blood 
mononuclear cells (PBMC) viability, apoptosis and mitochondrial function in the presence and absence 
of plasma antioxidants. Exposure to ozone increased lactate dehydrogenase (LDH) release and caspase 
3/7 activity in PBMC. A decrease in mitochondrial function was measured as a decrease in ATP levels 
and an increase in NADH/ NAD+ ratio. Complex IV (cytochrome c oxidase) of the respiratory chain was 
almost completely inhibited by ozone. These results indicated that the death of PBMC was probably 
through apoptosis. These effects were more evident in the absence of plasma antioxidants.  Therefore, 
high concentrations of ozone were damaging to the cells, but this effect was diminished by antioxidants 
present in plasma. It is not certain if the in vitro damage will be propagated when ozonated blood is 
injected back into individuals. One must bear in mind that only a fraction of the total blood volume is 
ozonated. 
 





Ozone is a powerful oxidant and its toxicity to the pulmo-
nary system is well known (Pryor et al., 1995).  Recently 
ozone has gained attention regarding its use as an alter-
native form of therapy. Ozone autohemotherapy (O3-
AHT) is a form of therapy where the blood of a patient is 
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en time and then reinfused back into the patient. The 
ozone dissolves in the plasma and reacts with organic 
molecules generating substances including lipid ozona-
tion products (toxic aldehydes), free radicals (mainly 
H2O2) and ozonides.  The current hypothesis is that these 
substances are responsible for the therapeutic response 
specifically, induction of cytokine release from PBMC 
(Bocci, 2002). These substances are also responsible for 
many toxic effects in PBMC including apoptosis (Larini et 
al., 2004) and DNA damage (Diaz-Llera et al., 2002).  
Many studies have focused on the harmful effects of 
ozone in the lung and have claimed that the toxic effects 
observed after inhalation of ozone are due to the ineffi-
cient antioxidant capacity of the lungs. The surfactant of 
the lung, the first compartment that comes in contact with 
ozone when inhaled, contains slightly lower antioxidant 
concentrations  than  plasma  (Mudway  and Kelly, 2000), 
   
 




but is well equipped (under normal circumstances) with 
antioxidants to counter the harmful effects. But ozone 
remains toxic and harmful when it is inhaled. Therefore 
the question is whether ozone can be toxic to blood even 
if its antioxidant defence system is more than adequate to 
deal with the reactive oxygen species (ROS) that are 
generated by ozone. 
Ozone reacts selectively with the haeme groups of hae-
moglobin, because it is recognized as oxygen (Cataldo 
and Gentilini, 2005). At the haemoglobin sites, it causes 
the oxidation of Fe (II) to Fe (III) in the hemin groups and 
this is followed by a complete breakdown of the porphyrin 
rings of haemoglobin. This reaction is similar to the reac-
tion of carbon monoxide (CO) with haemoglobin (Cataldo 
and Gentilini, 2005). CO also combines with the heame 
containing complex IV (cytocrome c oxidase) of the 
mitochondrial respiratory chain (Castoldi et al., 2005).   
We investigated the effects of O3-AHT with different 
concentrations of ozone on white blood cell apoptosis 
and mitochondrial function. We also investigated the eff-
ect of ozone on the respiratory chain complexes to deter-
mine if ozone reacts with complex IV. Study of the effects 
of ozone on cell cultures (e.g. lymphocytes) presents 
problems because due to the poor antioxidant capacity of 
media and serum results cannot be related to physio-
logical antioxidant capacity (Leist et al., 1996). In this 
study the effects of ozone, in comparison to oxygen, on 
PBMC were investigated under conditions similar to that 





Ozone generation and measurement 
 
Ozone was generated from ultra pure oxygen (>99.9 % BOC 
special products, Afrox) using electrical corona discharge by an 
ozone generator developed and build by the School of Physics, 
Potchefstroom Campus of the North-West University (USA patent 
09/914,199).  The ozone concentration was determined by a UV/Vis 
spectrophotometer (Pharmacia Biotech Ultraspec 3000) by 
measuring the gas absorbance at 254 nm ( = 3±0.03 mM-1.cm-1).  
The ozone concentration was monitored in real time, using a 
specially designed quarts cell containing an inlet, where gas 
entered from the ozone generator and an outlet, where the gas left 





The study was approved by the Ethics Committee of the North-
West University (05M07).  Blood (100 ml in EDTA) was collected 
from six apparently healthy human donors.  The blood was divided 
into two samples. In the first sample, venous blood was used 
unchanged for the treatment. In the second sample the blood plas-
ma was removed by differential centrifugation and the cells resus-
pended in phosphate buffered saline (PBS) before the treatment. 
These two samples of blood were then divided into four treatment 
groups that consisted of i) a control sample that received no treat-





samples treated with an ozone/oxygen gas mixture that contained 
either iii) 20 or iv) 80 µg/ml ozone. The whole blood and the buf-
fered cell samples were gently and continuously mixed with the 
gasses for 20 min. Thereafter the gas was carefully removed and 




Isolation of PBMC and cell viability 
 
PBMC were isolated from EDTA blood. The whole blood or buf-
fered cells were layered onto to Histopaque (Sigma-Aldrich, St. 
Louis, MO, USA) and centrifuged at 50 x g for 30 min. The cells 
(buffy coat layer) were removed, resuspended in PBS and collected 
by centrifugation (50 x g for 30 min). This washing step was repea-
ted twice. After removing the supernatant, the pellet was resus-
pended in RPMI1640 culture medium (Sigma-Aldrich, St. Louis, 




LDH release measurement 
 
The lactate dehydrogenase (LDH) release was measured in plasma 
or buffered saline by an enzymatic reaction according to the 
method of Decker and Lohmann-Matthes (1988). In this reaction 
NAD+ is reduced to NADH through conversion of lactate to pyruvate 
by LDH. NADH then reduce a tetrazolium salt, INT (2-[-4-iodophe-
nyl]-3-[4-nitrophenyl]-5-phenyltetrazolium chloride) to formazan in 
the presence of electron coupling agents or diaphorase (Decker 
and Lohman-Matthes, 1988). The resultant formazan absorbs at 
492 nm, which was spectrophotometrically measured in a BIO-TEK 
(FL600) microplate reader. The bicinchoninic acid (BCA) method for 
protein determination was done using bovine serum albumine 





Cysteine aspartic acid-specific protease of caspases 3 and 7 were 
measured using the Apo-ONE® Homogenous Caspase-3/7 assay 
kit as instructed by the supplier (Promega, Madison, WI, USA). The 
gas-treated and isolated WBC were counted and seeded into 96-
well plates with approximately 25 000 cells per well (final volume of 
100 µl). As positive control, cells were incubated with 1 µg/ml stau-
rosporine for 2 h. Fluorescence was measured at 30 min intervals 





The NADH/NAD+ ratio was determined by the method of Zeres et al 
(1990). Fluoride treated blood (20 µl) was mixed with 1980 µl of a 
buffer solution containing 10 mM nicotinamide, 20 mM NaHCO3 and 
100 mM Na2CO3 at 4°C (pH = 7.5). The mixture was snap frozen in 
liquid nitrogen, thawed at room temperature in a water bath and 
promptly chilled to 0°C. To destroy the oxidized forms of NAD+, 
1000 µl of this mixture was incubated at 60°C for 30 min in a dry 
heating block.  The samples were stored at -80°C until assayed.  
The reaction mixture was added to the sample and the absorbance 
read at 570 nm in BIO-TEK microplate fluorescence (FL 600) plate 
reader after four min. A standard curve with NADH was generated 
and used to quantify the concentration of NADH and NAD+ in each 
sample (Zerez et al., 1987,1990).  








Figure 1. The viability of ozone treated PBMC.  Results are 
given as mean ± 1SEM (n=6) cell viability (%) for the positive 
control (PC), whole blood (WB) and the buffered cells (BC) at 
baseline and after exposure to oxygen and 20 and 80 µg/ml 
ozone. p<0.05 (Bonferroni test) relative to the control (*) of the 






The ATP bioluminescent somatic cell assay kit (Sigma-Aldrich, St. 
Louis, MO, USA) was used to determine ATP content of treated 
WBC. The assay was normalized to the number of viable cells 
because of rapid degradation of ATP after cell death. WBC were 
seeded in a microtitre plate containing approximately 20 000 viable 
cells/well. The assay was performed according to instructions of the 
manufacturer. An ATP standard curve was used to quantify the 
amount of ATP present in samples. 
 
 
Isolation of rat liver mitochondria 
 
Liver from healthy Sprague-Dawly rats were removed after decapi-
tation, weighed and suspended in medium A (210 mM mannitol, 70 
mM sucrose, 50 mM Tris-HCl, 10 mM EDTA, pH 7.4 at 4°C) to a 
end concentration of 10 % (w/v). The tissue was homogenized 
using a Potter-Elvehjam homogenizer set at 200 rpm for 15 strokes. 
The homogenate was centrifuged at 1000 x g for five min at 4°C. 
The resulting supernatant was centrifuged at 7000 x g for 10 min at 
4°C. The supernatant was discarded at the mitochondrial-enriched 
pellet suspended in medium B (225 mM mannitol, 75 mM sucrose, 
10 mM Tris-HCl, 0.1 mM EDTA, pH 7.4 at 4°C) and the centrifuge 
steps repeated. The final mitochondrial pellet was suspended at 10 
mg/ml in medium B and kept on ice during assays respiration 




Mitochondrial respiration assay 
 
Respiration was measured using a MitocellTM (model MT 200) oxy-
gen electrode and recordingss were done using an OxymeterTM 
(Strathkelvin  Instruments  LTD, UK)  and  Oxygen System software  




(Strathkelvin 782, version 3.0). The reaction medium consisted of 
150 mM mannitol, 250 mM sucrose, 200 mM KCl, 20 mM Tris-
phosphate, 20 mM Tris-HCl (pH 7.5), 0.1mM EDTA and 0.25 mg/ml 
mitochondria in a reaction volume of 70 µl. The substrates that 
were used were 10 mM glutamate + 10 mM malate and 25 mM suc-
cinate + 3 µM rotenone. After recording state 2/4 respiration (ADP 
depleted) 2 mM ADP was added and state 3 respirations recorded.  
 
 
Respiratory chain enzyme assays 
 
All enzymatic determinations were done at 30°C on mitochondria 
isolated from liver homogentates as prepared for the respiration 
measurements. The complex I (NADH ubiquinone oxidoreductase), 
combined complex I and III (NADH:cytochrome c reductase), com-
bined complex II and III (succinate-cytochrome c reductase) and 
complex IV (cytochrome c oxidase) activities were determined 
according to the methods described before (Rahman et al., 1996). 
Enzyme activities were normalized to citrate synthase activity 





All statistical analyses was done using Graphpad Prism® 
(GraphPad Software Inc., San Diego, CA,USA, version 4) software 
package.  Results were expressed as the mean ± 1 standard error 
of the mean (1SEM). In order to measure the level of statistical 
difference, the distribution of the data was determined with normal 
probability plots. To determine the variation between the means 
values of each of the groups, an analysis of variance (ANOVA) was 
done. The repeated measure ANOVA was used because different 
treatments were given to the same individual and each individual 
served as his/her own control. In cases where significant different-
ces were measured, the Bonferroni post-hoc test was used to 
determine the extent of significance between the different groups. 





Cell viability, LDH release and caspase 3/7 activity 
 
Following exposure to 20 and 80 µg/ml O3 cell viability as 
measured with trypan blue exclusion decreased signifi-
cantly by 16 and 17% respectively (Figure 1). Without 
treatment viability of buffered cells decreased only slightly 
due to removal of plasma. This is important since remo-
val of the plasma and resuspending the cells in PBS 
without further treatment did not markedly affect cell via-
bility. Exposure to oxygen significantly decreased cell via-
bility by approximately 11%. Ozone treatment caused fur-
ther damage to the buffered cells since viability decrea-
sed by 24% and 26% after exposure of 20 and 80 µg/ml 
ozone respectively. Although cell viability decreased, it 
remained significantly higher than in the positive control 
cells, which were treated with 6% acetic acid. LDH relea-
se is considered a sensitive assay to measure cell necro-
sis (Decker and Lohman-Matthes, 1988). In whole blood 
LDH released from cells increased by 49% after treat-
ment with oxygen (Figure 2). Exposure to 20 µg/ml and 
80  µg/ml  ozone  increased  the LDH release significantly  
   
 






Figure 2. The LDH release from ozone treated PBMC.  
Results are given as mean ± 1SEM (n=6) LDH release (%) for 
the positive control (PC), whole blood (WB) and the buffered 
cells (BC) at baseline and after exposure to oxygen and 20 
and 80 µg/ml ozone.  p<0.05, relative to the control (*) of the 
whole blood (Bonferroni test). The positive control (PC) was 






Figure 3. The caspase 3/7 activity of ozone treated PBMC.  
Results are given as the mean ± 1SEM (n=6) caspase 3/7 
activity (AU/min/µg protein) for whole blood (WB) and buffered 
cells (BC) at baseline and after exposure to oxygen and 20 
and 80 µg/ml ozone. p<0.05 with respect to control (*) of the 
whole blood group (Bonferroni test). The positive control (PC) 





by 50 and 79%, respectively. LDH release from untreated 
buffered cells did not differ significantly from that of whole 
blood. Treatment of buffered cells with oxygen and the 
different concentrations of ozone increased LDH release 
significantly by 23, 50 and 49% after treatment with oxy-
gen and 20 and 80 µg/ml ozone,  respectively.   
The mean control levels of caspase 3/7 activity in the 
whole blood group was 1.04 AU/min/µg and after oxygen 
treatment this increased by approximately 16% to 1.24 
AU/min/µg (Figure 3). In whole blood the caspase activity 
increased significantly after exposure to 20 and 80 µg/ml 
ozone by approximately 56 and 68% respectively, when 
compared to the control. The ozone treated groups also 
differed significantly from the oxygenated samples. The 
mean control caspase activity of the buffered cells was 
approximately 20% (1.30 AU/min/µg) higher than that of 
the whole blood. This was not significantly different. The 
oxygenated samples were also not significantly different. 
The caspase activity of the ozone treated buffered cells 
increased by 60 and 56% with 20 and 80 µg/ml ozone 





The NADH/NAD+ ratio: In this study the baseline NADH 
/NAD+ ratios ranged between 0.6 and 1.9. After treatment 
with oxygen and 20 µg/ml ozone the ratios in whole blood 
increased, but not significantly (Figure 4). With 80 µg/ml 
ozone treatment the ratio increased by 40%. In the 
buffered cells the ratios increased significantly following 
treatment with oxygen and 80 µg/ml ozone. The increase 
in the NADH/NAD+ ratio was brought about by both an 
increase in NADH and a decrease in NAD+.  
 
ATP levels: The ATP levels in the PBMC in whole blood 
and in buffered cells decreased slightly, but significantly 
after treatment with oxygen, 20 and 80 µg/ml ozone 
(Figure 5). The treated samples in the buffered cells also 
contained significantly less ATP than the oxygenated 
sample in whole blood.    
 
Mitochondrial respiration: To further determine the 
effects of ozone on mitochondrial function, respiration in 
ozone treated liver mitochondria was measured. The 
amount of mitochondria required for this and the respira-
tory chain complex enzyme analyses could not be obtai-
ned from blood. State 3 respiration using substrates 
entering reducing equivalents either through complex I 
(glutamate and malate) or II (succinate plus the complex I 
inhibitor, rotenone) were determined and the data is 
summarized in Figure 6. As can be seen respiration thro-
ugh complex II had in general higher respiration than 
through complex I, which is the time-dependent step of 
the respiratory chain. Oxygen treatment increased respi-
ration  which  may  be  due to a relatively better supply of  








Figure 4.  The NADH/NAD+ ratio measured in the two 
intervention groups.  Results are given as the mean ± 
1SEM (n=6) NADH/NAD+ ratios for whole blood (WB) 
and buffered cells (BC) at baseline and after exposure to 
oxygen and 20 and 80 µg/ml ozone. p<0.05 with respect 






Figure 5. The ATP levels measured in the two intervention 
groups.  Results are given as the mean ± 1SEM (n=6) ATP 
levels for whole blood (WB) and buffered cells (BC) at 
baseline and after exposure to oxygen and 20 and 80 µg/ml 
ozone. p<0.05 with respect to control (*) of the whole blood 
group (Bonferroni test).# % luminesence/µg cells. 




oxygen in the reaction. However, using both substrates, 
ozone treatment at 20 µg/ml significantly reduced 
respiration by approximately 68% (succinate) and 40% 
(glutamate and malate). With 80 µg/ml ozone treatment 
the decrease was even more significant with 89% and 
80% for the two substrates respectively. 
 
Respiratory chain enzyme activities: The direct effect 
of ozone treatment on individual enzyme complexes of 
the respiratory chain was investigated and summarized in 
Table 1. The same treatment protocol as for the res-
piration measurements was used. Treatment with oxygen 
caused significant decreases in complex I activity, 
combined complex II+III activity and complex IV activity, 
by 32, 27 and 50% respectively. This may be due to 
oxidation of reducing elements in these complexes. 
Treatment with the two ozone concentrations had no 
significant effect on complex I or combined complex I+III 
activity, but decreased complex II+III activity significantly.  
However, complex IV activity was even more significantly 





The main purpose of this study was to evaluate the effect 
of ozone on white blood cell viability and mitochondrial 
function under conditions similar to O3-AHT. It has been 
reported that ozone affects cell viability of cultured 
monocytes (Klestadt et al., 2005).  Exposure of PBMC to 
ozone also caused a dose dependent increase of DNA 
damage (Diaz-Llera et al., 2002). Under conditions of 
oxidative stress, ROS can damage chromosomal DNA 
and other cellular components. This can results in DNA 
degradation, protein denaturation and lipid peroxidation 
(Higuchi, 2004).  Thus, increased oxidative stress caused 
by ozone is likely to be responsible for the increased 
death of PBMC that we observed, since mechanical stre-
ss was not present. Ozone exposure increases the 
formation of H2O2 which can damage cells via the Fenton 
reaction. The ozone also reacts with polyunsaturated 
fatty acids (PUFAs) in the membranes of the cells, gene-
rating lipid ozonation products (LOP). This can further 
lead to the increased cell necrosis and can explain why 
LDH release increased. On the other hand, membrane 
damage due to ozone binding to PUFAs can damage the 
cell membrane and so increase LDH release, without 
causing necrosis to the cells. The LOP, particularly 4-
hydroxynonenal (HNE), is able to activate biochemical 
and immunological pathways. Studies proved that HNE 
cause apoptosis and the release of caspase 3 (Larini et 
al., 2004). Many cell death events displays apoptotic and 
necrotic features, which can make it difficult to distinguish 
between the two forms of cell death (LaCasse et al., 
2005). Since caspase 3/7 levels increased three fold due 
to  ozone treatment increased death of PBMC was proba-  
   
 




Table 1. The effect of ozone treatment on the activity of different respiratory chain complexes in rat liver 
mitochondria. 
 
Complex Control O2 O3 [20] O3 [80] 
complex I 308±22 210±38* 376±23 409±20 
complex I+III 430±20 383±4 413±28 482±35 
complex II+III 478±6 348±41* 249±14* 291±35* 
complex IV 2797±167 1396±101* 131±12* 129±7* 
 







Figure 6. Effects of ozone treatment of rat liver 
mitochondrial state 3 respiration. The bars represent the 
mean ± 1SEM state 3 respiration (µmol/min) measured 
after the addition of 2 mM ADP (n=3). p<0.05 versus the 
control (*) of the different substrates added. S = 




bly caused by apoptosis. In this case it would prove 
useful to measure the amount of LOP formed, in order to 
determine the relationship between the toxic aldehydes 
and caspase activity.  
ROS, cell death and apoptosis can not be mentioned in 
the same sentence without including the role of the mito-
chondria. Treatment with ozone decreased ATP levels 
(Figure 4) increased the NADH/NAD+ ratio (Figure 3) and 
caspase activity (Figure 2). This indicated that mitochon-
drial function was affected. Mitochondrial oxidative phos-
phorylation is the major ATP synthetic pathway in eukar-
yotes. Electrons liberated from reducing substrates 
(NADH) are delivered to oxygen via a chain of respiratory 
complexes (complex I-IV). The energy from the electro-
chemical gradient () across the inner mitochondrial 
membranes is used to drive ATP production by complex 
V (Wallace, 1999; 2001). The measurement of ATP 
levels is therefore a good indicator of mitochondrial 
function.   
The mitochondrial function of the liver homogenates 
indicated that ozone treatment decreased the rate of 
state 3 respirations. It also inhibited complex II+III and 
especially complex IV activity, probably by interacting 
with the Fe-S clusters in the respiratory complexes. Acute 
ROS exposure can inactivate the iron sulphur (Fe-S) 
centres of the electron transport chain complexes, resul-
ting in the shutdown of mitochondrial energy production 
(Wallace, 1999). The decreased complex IV activity could 
have been caused by ozone directly binding to complex 
IV, similar to its reaction with haemoglobin (Cataldo et al., 
2005). This corresponds to previous results where low 
concentrations of ozone caused 20% inhibition of com-
plex IV activity in fibroblasts (Van der Zee et al., 1987). It 
is important to note that control of mitochondrial oxygen 
consumption and ATP synthesis is shared by several 
steps of oxidative phosphorylation and this can vary 
according to the type of tissue. This implies that there is 
no limiting step in the regulation of respiration (Rossing-
nol et al., 2000). Control of oxidative phosphorylation in 
the liver is mainly done at the phosphorylation level by 
ATP synthase and the phosphate carrier. Therefore, 
decreases in complex IV activity have to exceed a critical 
value before a decrease in mitochondrial respiration can 
be observed. This is because there is an excess of active 
respiratory chain complexes that can serve as a reserve 
to compensate for a deficit (Rossingnol et al., 2003).  
This implies that, although ozone inhibits complex IV by 
95%, respiration still takes place through the other com-
plexes that was not inhibited, resulting in a less signifi-
cant inhibition of respiration by ozone (Figure 6).   
Another important consideration is that ATP can act as 
a switch between apoptosis and necrosis. Cells that are 
more dependent on ATP from oxidative phosphorylation 
are more likely to undergo necrosis, whereas cells that 
are more dependent on ATP from glycolysis are more 
likely to undergo apoptosis when the ATP levels decre-
ase (Li et al., 2003).  PBMC obtain most of their ATP by 
metabolism and oxidation of glucose (Arslan et al., 1984), 
but  it is not clear whether they depend more on oxidative  






phosphorylation or glycolysis for ATP. Apoptosis is com-
mon in PBMC, but is dependent on the specific subtype 
of cells, with T-lymphocytes more likely to undergo apop-
tosis than other cells (LaCasse et al., 2005). The inhibited 
mitochondrial function and decreased ATP levels could 
however have contributed to the initiation of apoptosis. 
This is achieved by the opening of the mitochondrial 
permeability transition pore (MPT) located in the inner 
mitochondrial membrane. A number of cell death-promo-
ting factors are located in the mitochondrial inner mem-
brane space, including cytochrome c, apoptosis-inducing 
factor and caspases. The opening of the MPT causes 
collapse of the membrane potential, swelling of the mito-
chondrial inner membrane and release of the death pro-
moting-factors. Opening of the MPT can also be media-
ted by excessive calcium uptake (Wallace, 1999).  This, 
together with the elevated caspase activity argues stron-
gly in favour of apoptosis as the mechanism of cell death 
in PBMC after exposure to ozone. Unfortunately the 
results as to the mechanism of cell death are inconclu-
sive. As a follow up, we therefore propose to design a 
study that will specifically investigate if ozone causes 
necrosis or apoptosis. This will have to include long term 
exposure with a follow up of several hours after blood is 
exposed to ozone. Such a study will include an in depth 
investigation in morphological and biochemical changes 





In conclusion, these results clearly indicates a significant 
inhibition of mitochondrial respiration, specifically through 
inhibition of cytochrome c oxidase (complex IV), that may 
then lead to reduced ATP production, increase of ROS, 
increased NADH/NAD+ ratio and apoptosis and/or necro-
sis. Antioxidants in plasma dampened these effects of 
ozone. This highlights the importance of the plasma anti-
oxidant defence system in protection against ROS. It is 
not certain that these in vitro effects will propagate when 
ozonated blood is reinjected back into the individual 
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